MMG
VRTX icon

Monetary Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Monetary Management Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Hold
565
– – 0.06% 190
2026
Q1 		$252K Buy
565
+10
+2% +$4.66K 0.06% 188
2025
Q4 		$252K Hold
555
– – 0.06% 184
2025
Q3 		$217K Hold
555
– – 0.05% 193
2025
Q2 		$247K Hold
555
– – 0.06% 188
2025
Q1 		$269K Sell
555
-50
-8% -$23.3K 0.07% 176
2024
Q4 		$244K Sell
605
-565
-48% -$262K 0.06% 186
2024
Q3 		$544K Sell
1,170
-50
-4% -$24K 0.14% 138
2024
Q2 		$572K Buy
1,220
+100
+9% +$43.4K 0.15% 129
2024
Q1 		$468K Buy
+1,120
New +$473K 0.13% 139
2021
Q3 		– Sell
-300
Closed -$60K – 352
2021
Q2 		$60K Hold
300
– – 0.02% 240
2021
Q1 		$64K Sell
300
-150
-33% -$32.9K 0.02% 227
2020
Q4 		$106K Hold
450
– – 0.03% 198
2020
Q3 		$122K Hold
450
– – 0.04% 182
2020
Q2 		$131K Hold
450
– – 0.05% 170
2020
Q1 		$107K Hold
450
– – 0.05% 163
2019
Q4 		$99K Hold
450
– – 0.04% 198
2019
Q3 		$76K Buy
+450
New +$79.6K 0.03% 213
2015
Q3 		– Sell
-250
Closed -$31K – 344
2015
Q2 		$31K Sell
250
-600
-71% -$75.6K 0.01% 280
2015
Q1 		$100K Buy
+850
New +$102K 0.04% 203

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Monetary Management Group's VRTX Position: Q2 2026 in Review

Monetary Management Group held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 565 shares worth $281K. The position accounts for 0.06% of the portfolio, ranked #190.

Monetary Management Group first reported a position in VRTX in Q1 2015 and has held it in 20 quarters since. The position peaked at $572K in Q2 2024. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Monetary Management Group held 565 shares of Vertex Pharmaceuticals worth $281K as of Q2 2026.
  • Monetary Management Group left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.06% of Monetary Management Group's portfolio in Q2 2026, its #190 holding.
  • Monetary Management Group first reported a position in Vertex Pharmaceuticals in Q1 2015 and has held it in 20 quarters since.
  • Monetary Management Group's Vertex Pharmaceuticals position peaked at $572K in Q2 2024.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Monetary Management Group's 13F filing for Q2 2026, filed 12 Aug 2026.